Hyunmi Choi is a Neurology physician affiliated with Columbia University. OpenAlex indexes 106 publications with 2,754 citations (h-index 29).
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
710 W 168th Street
New York, NY 100322699
Telephone
212-305-1742Registry record last updated 16 Feb 2010.
Industry payments
3 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Boston Scientific CorporationProgram year20221 payment
- SK Life Science, Inc.Program year20222 payments
- JAZZ PHARMACEUTICALS INC.Program year20221 payment
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Nervous system
100%Other antiepileptics85.5%Levetiracetam69%Lacosamide31%Part D<11 patientsAnti-epileptic Agent14.5%Zonisamide100%Part D<11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
NIH funding
1 NIH research award on record, funded 2022–2026 per NIH RePORTER. The latest:
- Effects of vascular risk factors on risk for dementia and stroke after late-onset epilepsy (EpilepsyCOG)
Columbia University Health Sciences
FY2026$754,601R01AG074355 - Effects of vascular risk factors on risk for dementia and stroke after late-onset epilepsy (EpilepsyCOG)
Columbia University Health Sciences
FY2025$741,409R01AG074355 - Effects of vascular risk factors on risk for dementia and stroke after late-onset epilepsy (EpilepsyCOG)
Columbia University Health Sciences
FY2024$773,880R01AG074355
Awards in the NIH RePORTER records where a principal investigator name matches this physician at an organization in their practice state. Latest award years shown; each row links to the project record on RePORTER.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
Similar KOLs
Other experts from the same institution or the same specialty.
Serge Przedborski, MD, PhD
Columbia University
Shonni Silverberg, MD
Columbia University
Mitchell Benson, MD
Columbia University
Andrew Lassman, MD
Columbia University
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”